Racial and Socioeconomic Disparities in Pediatric Heart Transplant Outcomes in the Era of Anti-Thymocyte Globulin Induction

被引:0
|
作者
Carlo, W. F. [1 ]
Padilla, L. A. [2 ]
Xu, W. [3 ]
Carboni, M. P. [4 ]
Kleinmahon, J. A. [5 ]
Sparks, J. D. [6 ]
Rudraraju, R. [7 ]
Villa, C. [8 ]
Singh, T. P. [9 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Alabama Birmingham, Surg, Birmingham, AL USA
[3] Arkansas Childrens Hosp, Pediat Cardiol, Little Rock, AR USA
[4] Duke Univ, Pediat Cardiol, Durham, NC USA
[5] Ochsner Hlth, Cardiol, New Orleans, LA USA
[6] Norton Childrens Hosp, Pediat, Louisville, KY USA
[7] Univ Alabama Birmingham, Kirklin Inst Res Surg Outcomes, Birmingham, AL USA
[8] Cincinnati Childrens Hosp, Cardiol, Med Ctr, Cincinnati, OH USA
[9] Boston Childrens Hosp, Cardiol, Boston, MA USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
203
引用
收藏
页码:S96 / S97
页数:2
相关论文
共 50 条
  • [21] Short Term Outcomes in Kidney Transplant Patients Receiving De Novo Belatacept with Anti-Thymocyte Globulin Induction
    Carlson, B.
    Cabrera, P.
    Harrison, T.
    Tejani, K.
    Centeno, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 910 - 910
  • [22] LOWER PLATELET COUNT AFTER ANTI-THYMOCYTE GLOBULIN INDUCTION IS ASSOCIATED WITH LOWER INCIDENCE OF HEART TRANSPLANT REJECTION
    Skoric, Bosko
    Fabijanovic, Dora
    Reschner, Ana
    Macek, Jana Ljubas
    Cikes, Maja
    Samardzic, Jure
    Jurin, Hrvoje
    Gasparovic, Hrvoje
    Ivancan, Visnja
    Milicic, Davor
    TRANSPLANT INTERNATIONAL, 2019, 32 : 340 - 340
  • [23] Safety and Efficacy of CD3 Guided Anti-Thymocyte Globulin Dosing after Pediatric Heart Transplant
    Jackson, R.
    Heyrend, C.
    Fullerton, C.
    Benefield, E.
    Ensign, R.
    Molina, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S455 - S455
  • [24] Dose Reduction of Anti-Thymocyte Globulin for Kidney Transplant Induction: Possible Cost Savings?
    Chaung, M.
    Hollinger, E.
    Brokhof, M.
    Alvey, N.
    Lineberger, L.
    Kenyon, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 916 - 916
  • [25] Comparison of basiliximab to rabbit anti-thymocyte globulin induction in kidney transplant recipients.
    Ahmad, I
    Ketel, B
    Barone, G
    Barri, Y
    Reed, K
    Almquist, G
    Abulezz, S
    TRANSPLANTATION, 2000, 69 (08) : S159 - S159
  • [26] Comparison of Anti-Thymocyte Globulin and Alemtuzumab as Induction Therapy in Older Kidney Transplant Recipients
    Chaung, M.
    Hollinger, E.
    Brokhof, M.
    Alvey, N.
    Lineberger, L.
    Kenyon, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 916 - 916
  • [27] Efficacy of Early Steroid Withdrawal with Anti-Thymocyte Globulin Induction - Optimal Dose of Anti-Thymocyte Globulin in Korean Kidney Transplantation -
    Park, J. B.
    Chng, Y. S.
    Kim, Y. H.
    Song, K. B.
    Jung, J. H.
    Kim, S-C
    Han, D. J.
    TRANSPLANTATION, 2012, 94 (10) : 989 - 989
  • [28] ANTI-THYMOCYTE GLOBULIN INDUCTION COMBINED WITH DELAYED INTRODUCTION OF TACROLIMUS PRESERVES RENAL FUNCTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
    Rogers, Michael Evan
    Peters, Anna L.
    HEPATOLOGY, 2021, 74 : 1155A - 1156A
  • [29] DOES ANTI-THYMOCYTE GLOBULIN INDUCTION TRULY LEAD TO INCREASED CYTOMEGALOVIRUS INFECTION AFTER HEART TRANSPLANTATION IN THE CURRENT ERA?
    Mersola, S.
    Dimbil, S.
    Levine, R.
    Passano, E.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 100 - 101
  • [30] Safety of Cumulative Dose Anti-Thymocyte Globulin in Lung Transplant
    Pham, C.
    Chaplain, A.
    Pierce, B. J.
    Nguyen, D. T.
    Graviss, E. A.
    Goodarzi, A.
    Yau, S. W.
    Youssef, J. G.
    Huang, H. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S372 - S373